Preclinical Medical Device Testing Services Market is expected to reach a valuation of US$ 6.3 Billion by 2032 | FMI

The global Preclinical Medical Device Testing Services Market was worth US$ 2.8 billion in 2022 and is expected to be worth US$ 6.63 billion by 2032, growing at a CAGR of 9% during the forecast period. Preclinical medical device testing services market growth can be attributed to increasing product complexity and stringent government regulations. The market for preclinical medical device testing services grew at a 5.5% CAGR from 2017 to 2021.

Integration of artificial intelligence along with Internet of Things is playing a key role in advancing preclinical medical device testing services. In addition, the growing burden of treating diseases at an early stage is creating opportunities for the development of preclinical medical device testing services. Manufacturers too are researching and analyzing preclinical devices to solve problems related to the same at an early stage. This, in turn, is driving the demand for preclinical medical device testing services.

Get a PDF Sample with the Latest Market Insights @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14994

On the contrary, incompatible sterilization measures along with equipment sensitivity is derailing the progress of the market. In addition, approvals of preclinical medical devices differ from region to region. This, in turn, is hampering the growth of the overall market.

Key Takeaways from the Market Study

  • Global preclinical medical device testing services market is expected to flourish 3x from 2022-2032
  • Microbiology and sterility testing expected to possess a market share for 35%
  • U.S projected to lead the market by expanding at a CAGR of 18% during the forecast period.
  • India expected to register a CAGR of 13% for preclinical medical device testing services in the assessment period 2022-2032
  • Switzerland to be an emerging hub across Europe, expected to reflect a 10% value CAGR until 2032

“Increasing burden of diseases and strict governmental regulations for safety of patients is positively influencing the demand for preclinical medical device testing services,” states a FMI analyst.

Have a Conversation with the Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-14994

Competitive Landscape

  • SGS SA
  • Eurofins Scientific
  • Intertek Group Plc
  • WUXI APPTEC
  • TÜV SÜD AG
  • Sterigenics International LLC
  • Nelson Labs
  • North American Science Associates Inc.
  • Charles River Laboratories International Inc.
  • Pace Analytical Services LLC

Some of the recent key developments among the players are:

  • In February 2022, Eurofins acquired Genetic Testing Service JSC from Vietnam. Through this expansion, the company is planning to expand its presence in Asia and strengthen its global network of advanced genetic testing.
  • In September 2021, Nelson Labs and Sterigenics have collaborated to open a state of art laboratory and expand sterilization facilities to meet growing customer demand in Europe.

Order a Complete Research Report @ https://www.futuremarketinsights.com/checkout/14994

Key Segments Profiled in the Preclinical Medical Device Testing Services Industry Survey

Preclinical Medical Device Testing Services by Service:

  • Biocompatibility Tests
  • Chemistry Test
  • Microbiology & Sterility Testing
    • Bioburden Determination
    • Pyrogen & Endotoxin Testing
    • Sterility Test and Validation
      • Ethylene Oxide (EO) gas sterilization
      • Gamma-irradiation
      • E-beam Sterilization
      • X-ray Sterilization
      • Antimicrobial Activity Testing
      • Others
  • Package Validation

Explore FMI’s Extensive ongoing Coverage in Healthcare Domain:

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedInTwitterBlogs

Leave a comment

Your email address will not be published. Required fields are marked *